The Effects of Metformin on the PI3K/AKT Pathway in Anaplastic Thyroid Cancer Cell Lines

被引：0
|
作者：
Nozhat, Z. [1 ,2 ]
Hedayati, M. [1 ]
Zarkesh, M. [1 ]
Mohammadi-Yeganeh, S. [2 ]
Tabaei, K. [1 ]
Azizi, F. [3 ]
机构：
[1] Res Inst Endocrine Sci, Cellular & Mol Endocrine Res Ctr, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Sch Adv Technol Med, Dept Biotechnol, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran
来源：
EUROPEAN JOURNAL OF HUMAN GENETICS | 2019年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P12.011C
引用
收藏
页码：395 / 395
页数：1
相关论文
共 50 条
  • [1] Effects of metformin on the PI3K/AKT/FOXO1 pathway in anaplastic thyroid Cancer cell lines
    Nozhat, Zahra
    Mohammadi-Yeganeh, Samira
    Azizi, Feridoun
    Zarkesh, Maryam
    Hedayati, Mehdi
    DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 26 (02): : 93 - 103
  • [2] Effects of metformin on the PI3K/AKT/FOXO1 pathway in anaplastic thyroid Cancer cell lines
    Zahra Nozhat
    Samira Mohammadi-Yeganeh
    Feridoun Azizi
    Maryam Zarkesh
    Mehdi Hedayati
    DARU Journal of Pharmaceutical Sciences, 2018, 26 : 93 - 103
  • [3] The effects of PI3K/Akt/mTOR pathway inhibitors on a panel of NSCLC cell lines
    Heavey, S.
    Barr, M.
    O'Byrne, K.
    Gately, K.
    LUNG CANCER, 2012, 75 : S3 - S3
  • [4] Anillin interacts with RhoA to promote tumor progression in anaplastic thyroid cancer by activating the PI3K/AKT pathway
    Yu, Shi-Tong
    Sun, Bai-Hui
    Ge, Jun-Na
    Wei, Zhi-Gang
    Zhang, Zhi-Cheng
    Chen, Wei-Sheng
    Li, Ting-Ting
    Lei, Shang-Tong
    ENDOCRINE, 2025, 88 (01) : 211 - 222
  • [5] The PI3K/AKT/mTOR signaling pathway inhibitors enhance radiosensitivity in cancer cell lines
    Mardanshahi, Alireza
    Gharibkandi, Nasrin Abbasi
    Vaseghi, Samaneh
    Abedi, Seyed Mohammad
    Molavipordanjani, Sajjad
    MOLECULAR BIOLOGY REPORTS, 2021, 48 (08) : 6167 - 6180
  • [6] The PI3K/AKT/mTOR signaling pathway inhibitors enhance radiosensitivity in cancer cell lines
    Alireza Mardanshahi
    Nasrin Abbasi Gharibkandi
    Samaneh Vaseghi
    Seyed Mohammad Abedi
    Sajjad Molavipordanjani
    Molecular Biology Reports, 2021, 48 : 1 - 14
  • [7] PI3K/Akt signalling pathway and cancer
    Vara, JAF
    Casado, E
    de Castro, J
    Cejas, P
    Belda-Iniesta, C
    González-Barón, M
    CANCER TREATMENT REVIEWS, 2004, 30 (02) : 193 - 204
  • [8] The Effects of PI3K/Akt/mTOR Pathway Inhibitors on a Panel of Non Small Cell Lung Cancer (NSCLC) Cell Lines
    Heavey, Susan
    Barr, Martin
    Davies, Anthony
    O'Byrne, Ken
    Gately, Kathy
    CLINICAL CANCER RESEARCH, 2012, 18 (10)
  • [9] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
  • [10] PI3K/AKT Pathway and Its Mediators in Thyroid Carcinomas
    Zahra Nozhat
    Mehdi Hedayati
    Molecular Diagnosis & Therapy, 2016, 20 : 13 - 26
12345